>
pdufa.bio

Bemnifosbuvir-Ruzasvir

Updated ยทnext FDA decision on the calendar

Bemnifosbuvir-Ruzasvir is a Atea Pharmaceuticals, Inc. program. Its next catalyst is a Readout in Dec 2026. Every date links its source.

AVIR catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Atea Pharmaceuticals, Inc. (AVIR). We track 2 catalyst events for this program: 1 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Sep 2026AVIRReadout · Dec 2026AVIR

Questions

When is Bemnifosbuvir-Ruzasvir's next FDA decision or readout?

The next tracked catalyst for Bemnifosbuvir-Ruzasvir is a Readout in Dec 2026.

What happened at Bemnifosbuvir-Ruzasvir's most recent FDA decision?

No FDA decision for Bemnifosbuvir-Ruzasvir is in our archive yet.

Who makes Bemnifosbuvir-Ruzasvir?

Atea Pharmaceuticals, Inc. (AVIR).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.